<b>Methods</b>: Clinical tissue-based analyses, bioinformatic analyses of publicly available datasets, in vitro and in vivo functional assays, and targeted metabolomic profiling were performed to evaluate CALB2 in COAD. The gene discussed is CALB2; the disease is colon adenocarcinoma.